NASDAQ NMS - GLOBAL MARKET · LPCN

-2.43% · -$0.0600 · Vol 25.3K

Market closed · last close 4:00 PM ET · price as of 16:00:00 ET

Lipocine Inc

Pharmaceuticals

$2.41

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is LPCN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move LPCN next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Form 4 / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 10
Score
Score moved +46
15/AVOID -> 61/BUY BIAS
Veridion score historySource
Jun 4
Form 4Sovereign
Higuchi John W. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 4
Form 4Sovereign
Jene Jill M. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 4
Form 4Sovereign
Ono Richard Dana Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 7
Form 4Sovereign
Higuchi John W. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 6
Form 4Sovereign
Higuchi John W. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 6
Form 4Sovereign
Patel Mahesh V. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Apr 2
Form 4Sovereign
Patel Mahesh V. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jan 5
Form 4Sovereign
Patel Mahesh V. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Dec 19
Form 4Sovereign
Patel Mahesh V. Form 4 buy
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt

Catalyst calendar

Dated receipts for LPCN are being assembled.

About Lipocine Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2012

Employees

Country

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$2.45

Day high

$2.45

Day low

$2.38

Previous close

$2.47

52W high

$2.45

-1.63% from high

52W low

$2.38

43% of range

Market cap

$20.4M

EPS

$-1.8900

Shares out

8.2M

Volume

25.3K

VWAP

$2.42

Price history computed in-house

SMA 50 $2.42 · below

SMA 200 $2.42 · below

52W position 43%

Veridion warehouse edge

Warehouse intelligence for LPCN.

Veridion Score

0: 531: 352: 603: 574: 755: Not reported

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

LPCN insider activity

Lipocine Inc

Score

Coverage building

Pressure

Net buying

Filings

Buys / sells

10 / 0

Net value

$770K

Insiders

Named filers

Higuchi John W.

Insider

Leadership

Jene Jill M.

Insider

Leadership

Ono Richard Dana

Insider

Leadership

Cluster

3 insiders bought in the last 90 days

Net pressure

Net buying: $770K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-06-04	2026-06-03	Higuchi John W.	Insider	buy	$2.19	1,764	13,290	$4K	SEC Form 4
2026-06-04	2026-06-03	Jene Jill M.	Insider	buy	$2.19	1,764	8,938	$4K	SEC Form 4
2026-06-04	2026-06-03	Ono Richard Dana	Insider	buy	$2.19	1,764	13,290	$4K	SEC Form 4
2026-04-07	2026-04-07	Higuchi John W.	Insider	buy	$2.03	40,000	203,797	$81K	SEC Form 4
2026-04-06	2026-04-06	Higuchi John W.	Insider	buy	$2.05	123,000	163,797	$252K	SEC Form 4